MedTrace Logo

Effectiveness of Ketamine for Depression and Suicidal Ideation in the Emergency Department

NCT04266288 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2020-09-01

No results posted yet for this study

Summary

The purpose of this study is to examine the effect of a low-dose ketamine infusion on depression symptoms within the Emergency Department (ED) visit, and healthcare utilization after leaving the ED, when administered in the ED for depression or suicidal ideation.

Conditions

Interventions

DRUG

Ketamine

Active drug

DRUG

Sodium Chloride 0.9%

Placebo

Sponsors & Collaborators

  • MercyOne Des Moines Medical Center

    lead OTHER

Principal Investigators

  • Kathryn Bress, PharmD · MercyOne Des Moines Medical Center

  • Adnan Iqbal, MD · MercyOne Des Moines Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-18
Primary Completion
2020-05-31
Completion
2020-05-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04266288 on ClinicalTrials.gov